RetraLabs supplies both in India with COA and HPLC verification
It is not licensed by the MHRA or EMA and remains in Phase 3 clinical investigation
Starting dose and long-term protocol planning The starting dose is the first chapter, not the whole story
If considering a dose reduction for maintenance: Wait until weight has stabilized for at least 4 weeks at your current dose Reduce by one dose step (e.g., 12mg to 8mg), do not jump multiple steps Monitor weight closely for 8 weeks after the reduction If weight begins to increase, return to the previous maintenance dose The phase 3 trials specifically tested 4mg as a maintenance dose, suggesting Lilly sees viability in lower maintenance doses What happens if you stop Weight regain after discontinuing GLP-1 agonists is well documented with semaglutide and tirzepatide
Please contact the Drugs in Breastmilk team on if you need information on taking sulfonylureas whilst breastfeeding
While these medications suppress appetite effectively, they can inadvertently lead to insufficient protein consumption, increasing the risk of muscle loss alongside fat reduction
